Patients’ Perspectives and Challenges with Sacral Neuromodulation Implantable Pulse Generator
- 1Cleveland Clinic Foundation Glickman Urologic and Kidney Institute, Cleveland, OH USA
- 2Drexel University College of Medicine, Philadelphia, PA USA
Abstract
Introduction: Sacral neuromodulation (SNM) is an established therapy for refractory bowel and lower urinary tract dysfunction. While its efficacy and patient satisfaction are well documented, little is known about the physical burden of the implant itself. This study aimed to evaluate patient perspectives on the implantable pulse generator (IPG) placed in the gluteal region.
Methods: We reviewed 100 consecutive patients who underwent SNM within the past 2 years at a tertiary care center. Data were collected during follow-up visits or phone interviews using a five-question survey based on common patient concerns. Responses were analyzed descriptively, with statistical testing performed using SPSS version 29.
Results: Eighty-two patients received SNM for overactive bladder, 16 for urinary retention, and two for fecal incontinence. Sixty-two percent reported awareness of the IPG, 18% reported sleep or movement limitations, and 36% reported activity-related discomfort. Eleven percent turned off the device for non-MRI reasons. Overweight or obese patients (BMI >25) were less likely to report disturbances compared with normal-weight patients. Male patients were more likely than female patients to deactivate their device (P = 0.014), while older patients were less likely to turn it off.
Discussion: Most patients tolerated SNM well, though lower BMI was associated with greater discomfort, consistent with prior reports of higher revision rates in leaner individuals. Sex- and age-related differences suggest variations in device use behaviors, possibly due to lifestyle, activity level, or technological engagement.
Conclusion: SNM is generally well tolerated, but leaner, younger, and male patients may experience greater device-related burden, highlighting the need for tailored counseling and device optimization.
Related
- Transient defibrillation threshold elevation associated with air in the generator pocket after extravascular implantable cardioverter-defibrillator implantation.
- Past, Present, and Future Implantable Neuromodulation Treatments for Management of Urinary Urge Incontinence (UUI): Implications for Clinical Effectiveness and Safety
- Intracranial Hemorrhage in Patients Receiving Factor Xa Inhibitors: Challenges and Perspectives
- A qualitative study of care management challenges in patients with multiple sclerosis from patient, family caregiver and healthcare provider perspectives
- Understanding veteran perspectives surrounding implantable cardioverter- defibrillator decision-making.
BibTeX
@article{mansour2026patients,
title = {{Patients’ Perspectives and Challenges with Sacral Neuromodulation Implantable Pulse Generator}},
author = {Mazen Mansour and Alexander Fahmy and Maria D’Amico and Mohammad El Hussein and Tyler Trump and Mahmoud Abou Zeinab and Ahmad Albakr and Howard B. Goldman},
journal = {International Urogynecology Journal},
year = {2026},
month = jun,
doi = {10.1007/s00192-026-06756-8},
url = {https://doi.org/10.1007/s00192-026-06756-8},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Patients’ Perspectives and Challenges with Sacral Neuromodulation Implantable Pulse Generator
AU - Mazen Mansour
AU - Alexander Fahmy
AU - Maria D’Amico
AU - Mohammad El Hussein
AU - Tyler Trump
AU - Mahmoud Abou Zeinab
AU - Ahmad Albakr
AU - Howard B. Goldman
PY - 2026
DA - 2026/06/09
JO - International Urogynecology Journal
DO - 10.1007/s00192-026-06756-8
UR - https://doi.org/10.1007/s00192-026-06756-8
AB - Introduction: Sacral neuromodulation (SNM) is an established therapy for refractory bowel and lower urinary tract dysfunction. While its efficacy and patient satisfaction are well documented, little is known about the physical burden of the implant itself. This study aimed to evaluate patient perspectives on the implantable pulse generator (IPG) placed in the gluteal region. Methods: We reviewed 100 consecutive patients who underwent SNM within the past 2 years at a tertiary care center. Data were collected during follow-up visits or phone interviews using a five-question survey based on common patient concerns. Responses were analyzed descriptively, with statistical testing performed using SPSS version 29. Results: Eighty-two patients received SNM for overactive bladder, 16 for urinary retention, and two for fecal incontinence. Sixty-two percent reported awareness of the IPG, 18% reported sleep or movement limitations, and 36% reported activity-related discomfort. Eleven percent turned off the device for non-MRI reasons. Overweight or obese patients (BMI >25) were less likely to report disturbances compared with normal-weight patients. Male patients were more likely than female patients to deactivate their device (P = 0.014), while older patients were less likely to turn it off. Discussion: Most patients tolerated SNM well, though lower BMI was associated with greater discomfort, consistent with prior reports of higher revision rates in leaner individuals. Sex- and age-related differences suggest variations in device use behaviors, possibly due to lifestyle, activity level, or technological engagement. Conclusion: SNM is generally well tolerated, but leaner, younger, and male patients may experience greater device-related burden, highlighting the need for tailored counseling and device optimization.
SN - 0937-3462
SN - 1433-3023
ER -